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Mechanisms of Kidney Cell Injury from
Metals
by Bruce A. Fowler'
Themostenvironmentally abundant toxicmetals/metalloids (arsenic, cadmium, lead, andmercury)areeachknown
toproducecellinjury inthekidneybutthemolecularmechanismsunderlyingtheseeventsarenowbeingelucidated. It
isclearthatthenephrotoxicity oftheseagentsisdue, inpart, tothefactthaturinaryelimination isamajorrouteofex-
cretion fromthebody. Therole(s) ofmolecularfactorssuchasmetal-bindingproteins, inclusionbodies, andcell-specific
receptorlike proteinsthatappeartoinfluence renaltubulecellexpression, haveattractedincreasedinterestasdetenninants
thatmodulatecellpopulationsasspecial riskfortoxicity andrenalcancer. Thefutureofmechanistic toxicologystudies
with regardtohowandwhyonlycertainrenalcell populations becometargetsfortoxicity fromthesemetals/metalloids
and other less common inorganic nephrotoicants must focus on the molecular handlingofthese agents by target cell
populations.
Introduction
The mechanisms ofkidney cell injury from toxic metals are
only now being understood at the molecular leveldue to an in-
creased understanding ofhow theseagents arehandledby target
cellpopulations andtherolesofprotectivecellularmechanisms
in mediating toxicity at the cellular and molecular levels of
biological organization. This reviewexamines our current state
of knowledge with regard to how the most common toxic en-
vironmental metals/metalloids (lead, mercury, cadmium, and
arsenic) produce renal cell injury and the roles that molecular
factors such as metal-binding proteins and stress protein
responses may play in these processes. Particular attention is
given to the mechanisms underlying metal-induced alterations
in renal geneexpression and the importance that this phenom-
enon may have in both the cell injury process and induction of
renal cancer.
In addition, the known factors that may determine why only
only certain cells in certain portions ofthe primary functional
unitofthekidney, the nephron, are susceptible totoxicity from
individual toxic metals/metalloids are examined. The basic
physiology ofhandlingtoxinsby certainportionsofthenephron
is discussed from the perspective ofhow these transport pro-
cesses may influence the molecular mechanisms of toxicity
within these targetcellpopulations. Finally, thisreview exanines
possible newclasses ofbiological indicators ofrenal cellinjury
from toxic metallic agents because it is clear that new tests are
needed to detect chronic, low-level effects from these environ-
mentally dispersed metals/metalloids before clinical symptoms
ofchronic renal disease occur.
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Lead
Lead is the most ubiquitous ofthe nephrotoxic metals, and
humansareexposedtothisagentinair, food, andwater. Clinical
studiesinworkers(1-5)haveshownthedevelopmentofrenalin-
sufficiency, afterexposureto lead, andtherehavebeen several
casereportsofrenalcancer(6-8). Themechanismsunderlying
these phenomena are currently not understood, but animal
studies involving chronic exposure have demonstrated renal
tubulardamagecharacterizedbydevelopmentofpathognomonic
lead intranuclear inclusion bodies (Fig. 1) and renal cancer in
rodentsafterhigh-doseexposure (9). Thetoxiceffectsofleadon
thekidneyappeartobeprimarilylocalizedintheproximaltubule
(9-21). Physiological studies of lead transport in the kidney
(22,23)haveshownthatthismetalistakenupinproximaltubule
cells by a process that is inhibited by tin and several other
metabolicinhibitors. Brush-bordermembranevesicletransport
studies(24) haveshownthatleadistakenupbyextensive mem-
branebindingandpossibly by apassive transportmechanism.
Theintracellularhandlingofleadappearstomediated atlow
dosethelevelsby solublelead-bindingproteins (25), whichap-
peartoactinthemannerofreceptorstomediatethebioavilability
of Pb2+ to sensitive enzymes such as a-aminolevulinic acid
dehydratase (17,21,26-30)andmediatethe intranucleartransport
ofleadandchromatin-binding (29,30)withattendantchanges in
renal gene expression (31). A cleavage product of a2 micro-
globulin(32,33) istheprincipal leadbindingprotein(PbBp) in
renalproximal tubulecellsofrats (Fig. 2), whereasthehuman
(34) and monkey PbBPs appear to have similar ion exchange






FIGURE 1. Electron micrograph ofa renal proximal tubule cell showing the pathognomonic lead intranuclear inclusion body (arrow).
activity within target cell populations. It has been previously
hypothesized (33,35) thatthe well-known lead-induced altera-
tions in renal geneexpression (30,35-38) aremediatedbybin-
dingofthesePbBPstothe5'flankingregionsofgenesshowing
altered expression patterns such as outlined in Figure2. Inad-
dition, ifthereported (39)polymerization ofa2microglobulin
plays aroleintheformation ofthecytoplasmiclead-containing
inclusion bodies (17-20), thentheobserved temporal relation-
ship (31)betweenformationoftheseinclusions andcoincident
alterations inrenal gene expression becomes evenmore close-
ly linked. Further research is needed to complete ongoing
molecularbiology studiesconcerningtherelationshipsbetween
Pb2+ binding to the PbBP in rats, monkeys, and humans and







Mitrochondria. Renal proximal-tubule-cell mitochondria
havelongbeenknownfortheirsensitivitytolead(9,10,17,20,21),
with both morphological and biochemical alterations in struc-
ture/functional relationships. Inparticular, decreasedrespiratory
function, whichislinkedtodecreasedmorphological transfor-
mational capability (41), is ofclear importance with regard to
cell injury fromthis metal. Decreases inthe specific activities
ofmitochondrial-based hemepathwayenzymeshavealsobeen
reported (17,21). Overall, itisclearthatthisorganelle system is
ahighly sensitive, early target for lead in the kidney.
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FIGURE 2. A receptor-based hypothesis forexplaining howtherenal lead-binding proteincleavageproductofa2-microglobulinmay interact withtherenal prox-
imal tubule cell genome to alter the gene expression changes observed in this cell type.
Nuclei. Lead-induced alterations in renal gene expression







effects of lead at doses below those that procedure overt cell
death.
Mercury
The nephrotoxic effects ofmercurials have been known for
manyyears(43-46), andithasbeenclearthattheanatomical site
andmorphologicalmanifestationsoftoxicity arehighlydepen-
dentonthechemical formofthemercurial involved. Ingeneral,
inorganic mercury such as mercuric chlorideproduces effects
(43-45) on the third segment (S3) of the proximal tubule,
whereasorganomercurials suchasmethylmercurytendtopro-
duceeffectsonthesecond(S2)andthird(S3)segments,depend-















earliest ofthese phenomena and undoubtly plays a role in the
massive influx ofcalcium associated with cell deathafter ex-




Both organic and inorganic mercury exposure have been
shown tobothdamage renal proximal tubulecellmitochondria
(54-59), with loss ofrespiratory functionand alterations inkey
enzymes inthehemebiosyntheticpathway (54). Thesedecreases
in heme biosynthetic pathway enzymes are associated with
development of a characteristic porphyrinuria pattern (54),
which appearstobeofrenalorigin. Itisclearthatsuchdecreases
intheseessentialbiochemical processes mayplayanimportant
butasyet incompletely delineated roleinrenalcell injury from
these agents.
Lysosomes
Exposure to both inorganic and organic merurials (51) has
been showntoalterthestructureandfunctionoftherenal-tubule-
cell lysosome apparatus. This structural andbiochemical pertur-
bationoftherenallysosomal systembymercurialsmay resultin
thedevelopmentofproteinuria. Thereleaseofthemetal-binding
protein metallothionein, which binds mercury but notmethyl-
mercury into the urine, has been proposed as a possible bio-
logical monitoring testforexposureofpersonstomercury vapor.
Cadmium
In recent years, there has been intensive research into the
mechanisms underlying the well-documented proteinuria
(61,22) and calcuria (62) observed in persons after chronic
elevated exposure to cadmium. The metal-binding protein
metallothionein (MT) hasbeen shownby workers inanumber
oflaboratories to play several central roles in themechanisms
underlyingthesephenomena. Therehavebeenanumberrecent
reviews on this protein with regard to its chemistry and bio-
chemistry (63,64) butbriefly, cadmiummetallothionein (cdMT)
synthesized in the diver in response to cadmium exposure is
releasedintothecirculationandtransportedtothekidney, where
itis reabsorbedwithgreatefficiency (66,67) andrapidlydegrad-
ed (66-70), with the release ofCd2+ ionsthatstimulatethe syn-
thesis of MT within proximal tubule cells of the SI and S2
segments (67-70). Thisprocesscontinuesuntilthefinitecapacity
ofthecells isexceeded either asafunctionofchronic exposure
ordose. Once this threshold isexceeded, renal cell injury with
concomitant proteinuria and calcuria is initiated. The mecha-
nisms of Cd2+-induced renal tubule cell injury are described
below.
Lysosome System
The uptake anddegradationofCdMT in therenal proximal-
tubule cells is associatedwith the initial increasedpresence of
cadmium inthelysosomalfractions(67), followedoveraperiod
of several hours by the increased presence ofcadmium in the
cytosol, whereitisboundtobothrenal MTandanon-MTfrac-
tion. With thepassageoftime, thepercentageofCd2' bound to
the MT increases and that ofthe non-MT fraction decreases.
Studies from this laboratory have shown that it is the Cd2+
associated withthenon-MTfractionthatistemporallyassociated
with cytotoxicity (69,70). Theultrastructural appearanceofcells
exposed to parenteral doses of CdMT shows a characteristic
pattern of vesiculation and an increased number of electron-
denselysosomes (Fig. 3), andthis istemporally associated with
decreases in lysosomal protease activity (70), low molecular
weightproteinuria (69,70), andcalcuria(n2-75). Thesefindings
aresimilartothosenotedinpersonsexposedtocadmiumforpro-
longed timeperiods (62) as noted above. The interpretation of
these findings is that Cd2+ in the non-MT fractionis capable of
interfering with the normal process of lysosomal biogenesis,
which results inthedecreased reabsorption anddegradation of
low molecular weight proteins from the urinary filtrate, thus
resulting inatubularproteinuria similartothatobservedinper-
sonsexposedtocadmiumforlongtimeperiods. Atpresent, the
mechanism ofthe calcuria is unclear. Some data (72) indicate
thatmostofthecalciumintheurineisnonsionizedandprobably
proteinbounds suggestingthatitis secondary totheproteinuria,
whereas morerecentstudiesusing shortercollectiontimes (75)
have shownthatthe increased excretionofcalciuminthe urine
occurs before the main increases in protein excretion. Further
research is neededtoclarify the relationships between thepro-
teinuria andcalcuria.
Calmodulin
Toelucidate themechanisms ofcadmium-induced renal cell
injury, recentpreliminary in vitro studies (76,77) using CdMT
havefocusedonrelationships betweenmorphological alterations
inproximal tubulecells inculture, changes in intracellularCa2'
concentrations, and induction ofstress proteins. The results to
date indicate that induction of stress proteins followed by the
cellularvesiculationphenomenon shown in Figure 3 above oc-




a function of Cd2+ binding to effector molecules early in the
toxic process. A primary candidate for this role is calmodulin
because in vitro studies fromanumberoflaboratories (78-81)
have shownthat Cd2+ iscapable ofactivating thisprotein. Ac-




petition between MT and calmodulin for the Cd2+ ions and to
elucidate the role(s) of stress proteins in mediating Cd2+ in-
duced cell injury.
Arsenic
There are relatively few clinical reports ofarsenic-induced
kidneycellinjuryincomparisonwiththoseoflead,mercury, and
cadmium, but such caseshavebeendocumented (83). In com-
parisonwiththeothermetalsdiscussedabove, thechemical form
andoxidationstateofthearsenicalofconcern isofevenmoreim-
portance to understanding the mechanisms of cell injury. In-
organicpentavalentarsenic (As5+) andtrivalent arsenic (AS3+)
vary markedly in their acute toxicity and mechanisms of
biological action. Methylation of these inorganic forms to
methylarsonicacidanddimethylarsinicacidintheliverfurther
complicateanunderstandingofinvivorenaltoxicitybecausethey
are excretedby the kidney inthe urine.
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FIGURE 3. An electron micrograph ofa renal proximal-tubule cell from an animal given a single IP injectionofcadmium metallothionein 8 hrearlier, showing
characteristic vesiculation pattern and small, dense lysosmes.
Furthermore, early studies by Ginsburg (84,85) showed
arsenate (As5+) is activelytransported by thekidney tubules and
that a small fraction ofthis form is reduced toAS3+, which is the
more acutely toxic chemical form. These types ofdatagreatly
complicate any understanding ofthe mechanisms ofarsenical-
induced neurotoxicity because metabolic interconversion of
these arsenicals by the renal proximal tubule cells would yield
both species present.
Attheorganelleofbiologicalorganization, themitochondrion
is a major target site ofaction for all inorganic arsenicals (86).
Combinedultrastructural/biochemical studies (87)conducted on
kidneys ofrats exposed toarsenate (As5+) indrinking waterfor
prolongedperiodsoftimeshowedinsituswellingassociatedwith
decreased respiratory function. More recent studies (88) have
shown that exposure ofanimals to arsenic causes induction of
several stress proteins in the kidney, indicating that the genetic
machinery in the nuclei is also being affected by arsenical ex-
posure. It is not clear whether this phenomenon is a primary
response to arsenic entering the nucleus or secondary to other
aspectsofthecellinjuryprocesssuchasdecreasedenergy pro-
duction. Inany event, furtherresearch is neededtounderstand
how arsenicals are able to produce damage to proximal-tubule
cell structure and function.
Metal-Metal Interactions
It should be noted that the above discussion has considered
mechanismsofmetal-inducedrenalcellinjuryasifexposureoc-




be able to provide information in a such an exposure matrix.
Previous studies (89,90) using a lead-cadmium-arsenic
6162 B. A. FOWLER
exposure design have shown that combinations of these
metals/metalloids produce unique porphyrinuria patterns and
thatcadmiumexposurehasamarkedaffectontotalrenal uptake
of lead and the formation of inclusion bodies. More recent
studies (29,30) onthe renal PbBPhave shownthatcadmium is




aszinc andcadmium. Theotherinterestingmetal-metalloid in-
teraction is thatknown formercury and selenium, with forma-
tionofuniquecrystalloidintranuclearinclusionbodies(47). For-
mationofthesestructuresappearstoattenuatethenephrotoxicity
ofHg2+ inthekidney. Theimportanceoftheabovediscussion is
that it indicates theneedtoconsiderinteractions betweenmetals
in mechanism-based riskassessment situations wheremorethan
one element is present.
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